Official UK procurement notice
Provision of Testing Services and Sample Analysis
Authority: Public Health England
What is being bought
Published requirement descriptionPHE has been tasked by DHSC to urgently undertake a study to evaluate the immune response following COVID-19 vaccines as part of the National Immunisation Programme. This has been identified as a high national public health priority and a key aspect of this study requires taking 2000 samples for cellular work over a 24-month period. The UK Vaccines Taskforce have selected Oxford Immunotec as the sole supplier of T cell Testing for SARS-CoV-2 specific responses as part of the new COVID vaccine trials. Aligning PHE's study with this decision will ensure that it is consistent with the other vaccine studies performed within the UK, providing for comprehensive comparison and analysis to be carried out across all the different studies.
CPV: Laboratory services
The lotProcurement structure
single lot · no lot value publishedLot #1Oxford Immunotec will provide testing services and sample analysis to assist PHE in…
Oxford Immunotec will provide testing services and sample analysis to assist PHE in its evaluation of immune responses following COVID-19 vaccines used in the National Immunisation Programme.
Procedure terms & legal framework
From the official record- Procedure method
- Negotiated without publication of a contract notice
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 9 Feb 2021, 22:56 GMT
- Last source update
- 9 Feb 2021, 22:56 GMT
- FTS notice number
2021/S 000-002675- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0291daFind a Tender
- Why no open competition
The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons
- Published justification
The justification to source these services from Oxford Immunotec is to enable PHE to adhere with the decision made by the UK Vaccines Taskforce who selected Oxford Immunotec as the sole supplier of T cell Testing for SARS-CoV-2 specific responses as part of the new COVID vaccine trials. Oxford Immunotec was chosen as a result of the competitive process for its expertise in T cell measurement and its unique ability to provide T-SPOT® technology, the only globally regulated ELISPOT platform - which is currently being used clinically for identifying T cells made in response to another respiratory pathogen responsible for Tuberculosis.
Aligning with this verdict will ensure that the National Immunisation Programme being carried out by PHE is consistent with the other vaccine studies performed within the UK, providing for comprehensive comparison and analysis to be carried out across all the different studies. The Vaccines Taskforce has emphasised that it is important to be able to assess the different vaccines head-to-head and employing Oxford Immunotec's T-SPOT technology will measure the magnitude of the SARS-CoV-2 protein-specific T cell response of different vaccine candidates for cross-comparisons.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Oxford Immunotec LtdSubcontracting: declared | £240,000 † | — | Awarded |
Contracts
Contract 002675-2021-1 · Oxford Immunotec Ltd
- Signed
- 9 Feb 2021
- Value
- £240,000
- Status
- active
Contracting authority & participating public bodies
Dispute resolution & review bodies
- High Court and Court of Appeal of England and WalesReview body
Bidders & participating suppliers
1 commercial party on the notice- Oxford Immunotec LtdAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.